Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations

10 Jan 2023

Abstract excerpt

Importance: Proton pump inhibitors (PPIs) are increasingly used during pregnancy; however, several observational studies have raised concerns about an increased risk of specific types of congenital malformations. Objective: To examine the association between PPI exposure during early pregnancy and the risk of congenital malformations. Design, Setting, and Participants: This population-based cohort study used data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Issues in Pregnancy
Share to Gastroesophageal reflux and treatments
Share to Pregnancy and Medication Impact

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36626173
DOI: 10.1001/jamanetworkopen.2022.50366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital MalformationsPMID 36626173Read ↗

Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital MalformationsSemantic proximity Read ↗

Association between Maternal Drug Use and Cytochrome P450 Genetic Polymorphisms and the Risk of Congenital Heart Defects in Offspring.Semantic proximity Read ↗

Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the childSemantic proximity Read ↗

A NEW PERSPECTIVE ON ISOTRETINOIN IN PREGNANCY: PREGNANCY OUTCOMES, EVALUATION OF COMPLEX PHENOTYPES, AND IMPORTANCE OF TERATOLOGICAL COUNSELLINGSemantic proximity Read ↗

First trimester <scp>COVID</scp>‐19 and the risk of major congenital malformations–International Registry of Coronavirus Exposure in PregnancySemantic proximity Read ↗

Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital MalformationsSemantic proximity Read ↗

Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control studySemantic proximity Read ↗

Use of Corticosteroids in Early Pregnancy is Not Associated With Risk of Oral Clefts and Other Congenital Malformations in OffspringSemantic proximity Read ↗

Reassessing Metformin Safety in Pregnancy: Robust Disproportionality Mining of FAERS Uncovers De-novo Teratogenic Signals Across Multiple Fetal Organ SystemsSemantic proximity Read ↗

Associations and interaction effects of maternal smoking and genetic polymorphisms of cytochrome P450 genes with risk of congenital heart disease in offspring: A case-control study.Semantic proximity Read ↗

Risk of Adverse Pregnancy Outcomes Associated with Sodium Valproate(VPA): A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)Semantic proximity Read ↗

Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspringSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.